arrow
B

Brandy M. Heckman-Stoddard

national institutes of health (nih) - usa
H指数:21
被引数:2,277

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Trends in uterine cancer incidence and mortality: insights from a natural history model

Hazelton WD,Prest M,Chen L,Rouse K,Elkin EB,Ferris JS,等。子宫癌发病率和死亡率趋势:来自自然史模型的研究见解。国家癌症研究所杂志。(2025) 117(9):1891–903。doi: 10.1093/jnci/djaf135。

2025-08-011
PRE
Drug and biomarker tissue levels in a randomized presurgical trial on exemestane alternative schedules
2024-08-070
PRE
Collaborative Modeling to Compare Different Breast Cancer Screening Strategies

协作建模比较不同乳腺癌筛查策略

2024-06-1112
PRE
Exemestane and breast cancer prevention: how low can we go? Drug and biomarker tissue levels in a randomized presurgical trial on exemestane alternative dosing regimen
2024-05-020
PRE
A randomized Phase I pre-operative window trial of transdermal endoxifen in women planning mastectomy: evaluation of dermal safety, intra-mammary drug distribution, and biologic effects
2024-05-020
PRE
A randomized Phase I pre-operative window trial of transdermal endoxifen in women planning mastectomy: Evaluation of dermal safety, intra-mammary drug distribution, and biologic effects
2024-02-012
OAAI
Alternative dosing regimen of exemestane in a randomized presurgical trial: the role of obesity in biomarker modulation
2024-01-181
OA
Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ: A Randomized Clinical Trial
2023-12-012
PRE
A pre-surgical window trial of oral tamoxifen versus transdermal 4-hydroxytamoxifen gel in women with estrogen receptor positive duct carcinoma in situ (DCIS)
2023-03-010
PRE